REGULATORY FRAGMENTATION AND UNPROVEN STEM CELL THERAPIES: BEYOND HARMONIZATION (Hall 3G, L3)

Sponsored By 

Concurrent Speaker(s)

• 

  Jaime Imitola, MD (he/him/his)

  Neurology, Genetics andn Neuroscience
  Deparment of Neurology University of Connecticut, United States
• 

  Ji hyeon Ju

  Rheumatology/Seoul St.Mary's Hospital
  College of Medicine, The Catholic University of Korea, Republic of Korea
• 

  Marlena Pecyna, PhD, habilitation (she/her/hers)

  Civil Law Department, Faculty of Law and Administration
  Jagiellonian University , Poland
• 

  Yaojin Peng, PhD (he/him/his)

  Institution of Zoology, Chinese Academy of Sciences, China

This session will address the global regulatory challenges of unproven stem cell therapies, including the impact of inconsistent national regulations and public demand for innovative treatments. Experts will discuss the origins of regulatory fragmentation and strategies for achieving global alignment to ensure patient safety.

Presentations:

• JUDICIAL VARIABILITY IN THE REGULATION OF THE STEM CELL INDUSTRY IN CHINA
  

  Concurrent Speaker: Yaojin Peng, PhD (he/him/his) – Institution of Zoology, Chinese Academy of Sciences
• REGULATORY DISRUPTION AND UNPROVEN STEM CELL THERAPIES IN EAST ASIA: BEYOND HARMONY
  

  Concurrent Speaker: Ji hyeon Ju – College of Medicine, The Catholic University of Korea
• REGULATORY FRAGMENTATION AND UNPROVEN STEM CELL THERAPIES: BEYOND HARMONIZATION - EUROPEAN PERSPECTIVE
  

  Concurrent Speaker: Marlena Pecyna, PhD, habilitation (she/her/hers) – Jagiellonian University
• REGULATORY FRAGMENTATION AND UNPROVEN STEM CELL THERAPIES: NOVEL AWARENESS AND EDUCATIONAL STRATEGIES
  

  Concurrent Speaker: Jaime Imitola, MD (he/him/his) – Deparment of Neurology University of Connecticut